BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, May 12, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

Chinese group among three teams to report Zika, microcephaly link

May 18, 2016
By Anette Breindl
If any doubts still existed, several teams of researchers have reported the first direct experimental evidence that both Asian and Brazilian strains of Zika virus can cause microcephaly when they infect pregnant mice.
Read More

Viral adaptation favors HIV, predicts disease course

May 18, 2016
By Anette Breindl
The degree of pre-existing adaptation between a person's immune system and the precise genetic characteristics of the HIV that person was infected with could predict how quickly disease would progress, researchers reported in the May 16, 2016, online issue of Nature Medicine.
Read More

Bench Press: BioWorld looks at translational medicine

May 16, 2016
By Anette Breindl

Hormone increases fat absorption, obesity risk

May 16, 2016
By Anette Breindl
In research spanning cell lines to humans, researchers have demonstrated that the hormone neurotensin is necessary for a high-fat diet to lead to obesity. Mark Evers, director of the University of Kentucky Markey Cancer Center, told BioWorld Today that neurotensin may be one of the links between obesity and an increased risk of cancer. The team reported its results in the May 12, 2016, issue of Nature.
Read More

Broadly neutralizing HIV antibody points to novel vaccine target

May 13, 2016
By Anette Breindl
Scientists have discovered a broadly neutralizing antibody to HIV that binds to its fusion peptide. The antibody, which goes by the prosaic name of VRC34.01, is the first known broadly neutralizing antibody targeting that particular region of the virus.
Read More

Three teams report Zika models, microcephaly causal link

May 11, 2016
By Anette Breindl

If any doubts still existed, several teams of researchers have reported the first direct experimental evidence that both Asian and Brazilian strains of Zika virus can cause microcephaly when they infect pregnant mice.


Read More

Cheap, quick platform technology leads to cheap, quick Zika diagnostic test

May 10, 2016
By Anette Breindl

Cheap, quick platform technology leads to cheap, quick Zika diagnostic

May 10, 2016
By Anette Breindl
An experimental Zika diagnostic can rapidly and inexpensively detect Zika virus and determine its specific strain, opening up the possibility of much improved monitoring of the virus as it spreads through the Americas.
Read More

Bench Press: BioWorld looks at translational medicine

May 9, 2016
By Anette Breindl
Scientists from the German Leibniz Institute for Experimental Virology and the Bernhard Nocht Institute for Tropical Medicine have discovered that T-cell dysregulation is an important facet of the immune system response to Ebola virus disease.
Read More

Robot has co-STARring role in revolutionary soft tissue surgery

May 5, 2016
By Anette Breindl
Previous 1 2 … 172 173 174 175 176 177 178 179 180 … 401 402 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 11, 2026.
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • Neurology illustration

    Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst

    BioWorld
    Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing